Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07PYC
|
||||
Former ID |
DNC005615
|
||||
Drug Name |
3-Indan-(1Z)-ylidenemethyl-pyridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527456] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H13N
|
||||
Canonical SMILES |
C1CC(=CC2=CN=CC=C2)C3=CC=CC=C31
|
||||
InChI |
1S/C15H13N/c1-2-6-15-13(5-1)7-8-14(15)10-12-4-3-9-16-11-12/h1-6,9-11H,7-8H2/b14-10-
|
||||
InChIKey |
WDSJJUYCBHIJRT-UVTDQMKNSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527456] | |
Cytochrome P450 19 | Target Info | Inhibitor | [527456] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | SteroidogenesisPW000045:Androgen and Estrogen Metabolism | ||||
WikiPathways | Metapathway biotransformation | ||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Corticotropin-releasing hormoneWP702:Metapathway biotransformation | |||||
Tryptophan metabolism | |||||
Ovarian Infertility Genes | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compounds | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.